Financing channel feed – Endpoints News

Financing channel feed

As Roivant’s unicorn valuation swells to $7B, Ramaswamy scoops up $200M to back a new burst of startups

7 years ago

On the heels of an Eli Lilly deal, NextCure’s hot hand in I/O attracts a $93M trans-Pacific venture round

7 years ago

Merck, Amgen back a $30M play for Ribometrix — one of the upstarts making its mark in drugging RNA

7 years ago

Boehringer backs $33M cancer vaccine play at Switzerland's AMAL Therapeutics

7 years ago

Big dreams, big pay and a big IPO: Moderna lights up a pitch for a record $500M biotech IPO

7 years ago

Penn spinout preps for human studies of a new-model CAAR, aiming at a one-time cure for autoimmune diseases

7 years ago

InCarda grabs a $42M round to back PoC study for their inhaled cardio drug

7 years ago

Eyes on neuro breakthroughs, newcomer Biomatics adds biotech vets and $300M with second fund

7 years ago

Centrexion eyes $70M-$80M in IPO with big plans for PhIII non-opioid painkiller

7 years ago

Omeicos scores $19.5M in Series C to take its omega-3 drug to the next round

7 years ago

Tuning in: Intensity's immune-based chemo delivery tech attracts backing of British billionaire Jim Mellon

7 years ago

Gene therapy developer Orchard prices IPO at $14 to raise $200M

7 years ago

Finally! Innovent hikes on Hong Kong debut amid cloudy market sentiments

7 years ago

WuXi dives into computational drug discovery, launches New York-based JV with Schrödinger

7 years ago

Arch Venture sets its sights on raising $600M for Fund X

7 years ago

Terns scores $80M in Series B financing led by Vivo, OrbiMed

7 years ago

Julian Adams manages to complete his $50M IPO at Gamida Cell — at a heavy cost

7 years ago

Carving a pipeline out of troubled Teva, OrbiMed leads $60M launch of new NASH player

7 years ago

Novo-backed Galecto Biotech scores €79 million in Series C funding

7 years ago

Milestone Pharma grabs an $80M round as it steams into pivotal trial work, starts outlining commercial structure

7 years ago

Hong Kong IPO delivers $421M to Innovent as another one of China's biotech unicorns hauls in big money

7 years ago

Bain’s Adam Koppel commits $350M to launching a new biotech that is carving out Pfizer’s neuro pipeline

7 years ago

In key endorsement, Deerfield reserves $65M for drug venture with UNC-Chapel Hill

7 years ago

Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline

7 years ago

First page Previous page 120 121 122123124 125 126 Next page Last page